Adipotide vs Mazdutide — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Adipotide (FTPP) is an experimental peptidomimetic that selectively targets and destroys blood vessels supplying white adipose tissue. It consists of a homing peptide that binds prohibitin on adipose vasculature, linked to a proapoptotic sequence that triggers cell death in the t...
Calculate Adipotide dose →Mazdutide (IBI362) is a once-weekly GLP-1/glucagon receptor dual agonist developed by Innovent Biologics. By activating both receptors simultaneously, it combines the appetite suppression and insulin-sensitizing effects of GLP-1 agonism with the fat-oxidizing and energy-expenditu...
Calculate Mazdutide dose →| Parameter | Adipotide | Mazdutide |
|---|---|---|
| Category | Metabolic & Mitochondrial | Metabolic & Mitochondrial |
| Research | Preclinical | Phase III (China) |
| Half-Life | - | ~7 days |
| Typical Dose | 1 mg/kg body weight | 3–9 mg |
| Frequency | Daily (research cycles) | Once weekly |
| Route | Subcutaneous | Subcutaneous (weekly) |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.